Hindawi Publishing Corporation Journal of Toxicology Volume 2012, Article ID 756358, 21 pages doi:10.1155/2012/756358 Review Article Towards Therapeutic Applications of Arthropod Venom K+-Channel Blockers in CNS Neurologic Diseases Involving Memory Acquisition and Storage Christiano D. C. Gati,1, 2 Marcia´ R. Mortari,1 and Elisabeth F. Schwartz1 1 Departamento de Ciˆencias Fisiologicas,´ Instituto de Ciˆencias Biologicas,´ Universidade de Bras´ılia, 70910-900 Bras´ılia, DF, Brazil 2 Universidade Catolica´ de Bras´ılia, 71966-700 Bras´ılia, DF, Brazil Correspondence should be addressed to Elisabeth F. Schwartz,
[email protected] Received 29 December 2011; Accepted 8 February 2012 Academic Editor: Yonghua Ji Copyright © 2012 Christiano D. C. Gati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Potassium channels are the most heterogeneous and widely distributed group of ion channels and play important functions in all cells, in both normal and pathological mechanisms, including learning and memory processes. Being fundamental for many diverse physiological processes, K+-channels are recognized as potential therapeutic targets in the treatment of several Central Nervous System (CNS) diseases, such as multiple sclerosis, Parkinson’s and Alzheimer’s diseases, schizophrenia, HIV-1-associated dementia, and epilepsy. Blockers of these channels are therefore potential candidates for the symptomatic treatment of these neuropathies, through their neurological effects. Venomous animals have evolved a wide set of toxins for prey capture and defense. These compounds, mainly peptides, act on various pharmacological targets, making them an innumerable source of ligands for answering experimental paradigms, as well as for therapeutic application.